Abstract 799: CDKN2A mutation predicts immunotherapy resistance in stage III/IV NSCLC

Authors: Stanley I. Gutiontov, Sean Pitroda

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-799

Source: Full article

---

Abstract

Abstract